Helicobacter pylori and hypergastrinaemia during proton pump inhibitor therapy.

McColl, K E; Nujumi, A M; Dorrian, C A; Macdonald, A M; Fullarton, G M; Harwood, J

McColl, K E; Nujumi, A M; Dorrian, C A; Macdonald, A M; Fullarton, G M; Harwood, J.

Affiliation

McColl KE; University Dept. of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland.

Scand J Gastroenterol ; 27(2): 93-8, 1992.

Article in En | MEDLINE | ID: mdl-1532864

Subject(s)

Adenosine Triphosphatases/antagonists & inhibitors; Benzimidazoles/pharmacology; Gastrins/blood; Helicobacter Infections/blood; Helicobacter pylori; Pepsinogen A; Pepsinogens/blood; Peptide Fragments/blood; Sulfoxides/pharmacology; 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles/therapeutic use; Duodenal Ulcer/blood; Duodenal Ulcer/drug therapy; Duodenal Ulcer/metabolism; Gastric Acidity Determination; Gastrins/drug effects; Helicobacter Infections/metabolism; Humans; Male; Omeprazole/analogs & derivatives; Pantoprazole; Pepsinogens/drug effects; Peptide Fragments/drug effects; Sulfoxides/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pepsinogens / Peptide Fragments / Sulfoxides / Benzimidazoles / Gastrins / Helicobacter pylori / Helicobacter Infections / Adenosine Triphosphatases / Pepsinogen A Limits: Humans / Male Language: En Journal: Scand J Gastroenterol Year: 1992 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links